Palatin Technologies
PTN
#9823
Rank
ยฃ35.2 M
Marketcap
ยฃ20.68
Share price
28.62%
Change (1 day)
2,797.12%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -ยฃ13.14 Million

According to Palatin Technologies's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ20.26 Million, an increase over its 2023 earnings that were of -ยฃ24.38 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ13.14 Million-35.17%
2024 -ยฃ20.26 Million-16.9%
2023 -ยฃ24.38 Million5.99%
2022 -ยฃ23 Million-13.7%
2021 -ยฃ26.65 Million33.25%
2020 -ยฃ20 Million-172.11%
2019 ยฃ27.73 M2352.33%
2018 ยฃ1.13 M-94.13%
2017 ยฃ19.27 M-154.92%
2016 -ยฃ35.09 Million3.67%
2015 -ยฃ33.85 Million878%
2014 -ยฃ3.47 Million-72.64%
2013 -ยฃ12.65 Million-33.11%
2012 -ยฃ18.91 Million77.71%
2011 -ยฃ10.65 Million
2003 -ยฃ18.02 Million29.93%
2002 -ยฃ13.87 Million36.18%
2001 -ยฃ10.19 Million
1999 -ยฃ8.46 Million6.04%
1998 -ยฃ7.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-ยฃ8.88 Million-31.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-ยฃ22.18 Million 70.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.43 B-3,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ38.01 M-392.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ50.22 M-486.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ88.47 Million 580.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.36 B-187,443.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-ยฃ41.78 Million 221.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ9.84 B-75,798.43%๐Ÿ‡ฌ๐Ÿ‡ง UK